Autres langues Arecor Therapeutics plc

Actions

AREC

GB00BMWLM973

Recherche biotechnologique et médicale

Temps Différé London S.E. 13:05:29 28/09/2026			Varia. 5j.	Varia. 1 janv.
87,75 ^GBX	-0,85%		+0,29%	+9,01%

13/08	RÉSULTATS ET ACTIVITÉ : tinyBuild poursuit Max Ent ; les pertes de Light Science se creusent	AN
13/08	Arecor Therapeutics plc publie les données cliniques de l'AT278 dans une revue à comité de lecture	CI

Autres langues

13/08	EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows
13/08	Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal
28/04	Arecor Therapeutics plc Auditor Raises 'Going Concern' Doubt
13/04	Arecor Therapeutics swings to annual profit; hails insulin product
13/04	Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025
13/04	Earnings Flash (AREC.L) Arecor Therapeutics plc Reports FY25 Revenue GBP1.7M
26/03	LPA to meet consensus; Aptamer raises GBP4.28 million
26/03	Arecor Therapeutics Receives First Milestone Payment Under Ligand Royalty Deal
26/03	Arecor Therapeutics Receives $0.5 Million Milestone Payment from Ligand Pharmaceuticals
09/02	Arecor Therapeutics revenue falls after Tetris Pharma operations cease
04/11	Arecor Gains US, European Patents for Insulin Product Formulations, Intellectual Property
04/11	Arecor Therapeutics plc Enhances Ip Coverage for AT278 and Oral Delivery Technology
30/09/25	Arecor Therapeutics plc Announces Board Changes, Effective 29 September 2025
25/09/25	Seeing Machines loss narrows; Hansard profit falls
25/09/25	EARNINGS: Seeing machine loss narrows; Hansard profit falls
25/09/25	European stocks fade ahead of US data
25/09/25	AIM WINNERS & LOSERS: Proteome Sciences loss narrows but revenue falls
25/09/25	Arecor Signs New Co-Development, Royalty Financing Deals
25/09/25	Arecor Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2025
25/09/25	Arecor Therapeutics plc Signs Co-Development Agreement with Sequel Med Tech LLC
25/09/25	Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln
25/09/25	Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292
25/09/25	Earnings Flash (AREC.L) Arecor Therapeutics Reports H1 Revenue GBP2.0M
04/09/25	Gem Resources raises funds; Afentra Angolan progress
04/09/25	Arecor Receives Positive US FDA Feedback for Rapid-acting Insulin Study